ANVISA Updates Health Measures for Ports and Airports Amid Ebola Outbreak
Brazilian Health Regulatory Agency updates port and airport health protocols after WHO declares Ebola outbreak in Congo a Public Health Emergency of International Concern.
ANVISAFDA Issues Draft Guidance to Accelerate Cell and Gene Therapies for Patients
FDA draft guidance proposes leveraging existing platform knowledge to streamline development of cell and gene therapies for rare and life-threatening diseases.
FDAETF Recommends Updating COVID-19 Vaccines to Target XFG Variant
EMA's Emergency Task Force recommends updating COVID-19 vaccines to target the XFG variant for the 2026/2027 vaccination campaign.
EMAFDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
FDA draft guidance aims to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs, potentially accelerating timelines for human trials.
FDAEU recommendations for 2026/2027 seasonal flu vaccine composition
Annual updates to virus strains ensure vaccines stay effective
EMAEMA Recommends First Oral GLP-1 Treatment for Weight Management
EMA recommends first oral GLP-1 (semaglutide) for weight management, offering Wegovy tablets as an alternative to injections.
EMAFDA Finalizes Food Chemical Safety Program, Launches Reassessment of BHT and ADA
FDA finalized its post-market assessment program for food chemicals and launched reassessments of BHT and ADA.
FDAFDA Advances Drug Repurposing to Address Unmet Medical Needs
FDA is soliciting public input on drug repurposing to accelerate treatments for chronic and rare diseases.
FDAFDA Intensifies Efforts to Import Lower-Cost Drugs
FDA Intensifies Efforts with States to Import Lower-Cost Canadian Drugs.
FDAShowing 25 to 27 of 27 results